Data as of 1:06pm ET
| +0.06 / +0.25%|
The 7 analysts offering 12-month price forecasts for Idenix Pharmaceuticals Inc have a median target of 9.00, with a high estimate of 24.50 and a low estimate of 3.00. The median estimate represents a -63.08% decrease from the last price of 24.38.
The current consensus among 8 polled investment analysts is to Hold stock in Idenix Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.